Pharmacokinetics of BF2.649 in Renal Impairment

Status:
Completed

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

This is an open, parallel group study in subjects with normal renal function compared to those with renal dysfunction.

Phase 1

Bioprojet